These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 36810098)

  • 1. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
    Wu B; Shi X; Jiang M; Liu H
    Mol Cancer; 2023 Feb; 22(1):38. PubMed ID: 36810098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
    Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
    Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.
    Li X; Zhang C; Yue W; Jiang Y
    Front Immunol; 2024; 15():1362120. PubMed ID: 38962016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development.
    Meldolesi J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.
    Bhavsar C; Momin M; Khan T; Omri A
    Expert Opin Drug Deliv; 2018 Jul; 15(7):641-663. PubMed ID: 29301448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
    Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
    Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion.
    Sarabia-Sánchez MA; Tinajero-Rodríguez JM; Ortiz-Sánchez E; Alvarado-Ortiz E
    Life Sci; 2024 Oct; 355():123015. PubMed ID: 39182567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.
    Rouzbahani E; Majidpoor J; Najafi S; Mortezaee K
    Biomed Pharmacother; 2022 Dec; 156():113906. PubMed ID: 36306594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.
    Zhu M; Li S; Cao X; Rashid K; Liu T
    Semin Cancer Biol; 2023 Jan; 88():18-31. PubMed ID: 36410636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
    Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
    Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An emerging role for cellular crosstalk in the cancer stem cell niche.
    Oshimori N; Guo Y; Taniguchi S
    J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives.
    Scioli MG; Terriaca S; Fiorelli E; Storti G; Fabbri G; Cervelli V; Orlandi A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Cancer Stem Cells Microenvironment.
    Naik PP; Panda PK; Bhutia SK
    Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity.
    Chulpanova DS; Rizvanov AA; Solovyeva VV
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.